How Bacteria Cause Disease: Pathogenesis Explained

Bacteria use adhesion, toxins, immune evasion, and biofilms to cause disease. Understanding bacterial pathogenesis drives antibiotic development and infection control strategies.

The InfoNexus Editorial TeamMay 16, 20269 min read

Most Bacteria Don't Cause Disease — But Some Have Mastered the Art

The human body hosts roughly 38 trillion bacterial cells — comparable to the number of human cells. The vast majority are harmless or beneficial. But a small fraction have evolved sophisticated arsenals for breaching host defenses, colonizing tissues, acquiring nutrients, and evading immune destruction. The science of how they do this — bacterial pathogenesis — is fundamental to understanding infectious disease.

Stages of Bacterial Infection

A successful bacterial infection proceeds through defined stages:

  1. Transmission — bacteria reach a new host via droplets, food, water, direct contact, or vectors
  2. Adherence — bacteria attach to host surfaces using specialized adhesins
  3. Colonization — bacteria multiply at the infection site
  4. Invasion — some pathogens penetrate deeper tissues or cells
  5. Evasion — bacteria resist immune defenses
  6. Damage — disease symptoms emerge from toxins, inflammation, or tissue destruction

Virulence Factors

Virulence factors are bacterial products or structures that contribute to pathogenesis. They are often encoded on pathogenicity islands — clusters of genes acquired through horizontal gene transfer from other bacteria.

Virulence FactorExample BacteriaFunction
Pili / fimbriaeE. coli, N. gonorrhoeaeAdhesion to epithelial cells
CapsuleS. pneumoniae, K. pneumoniaeBlocks phagocytosis
ExotoxinsC. botulinum, V. choleraeDamage host cells or disrupt physiology
Endotoxin (LPS)Gram-negative bacteriaTriggers inflammatory response
Invasion proteinsSalmonella, ShigellaForce non-phagocytic cells to ingest bacteria
BiofilmP. aeruginosa, S. aureusProtects against antibiotics and immune cells

Toxins: Chemical Weapons

Bacterial toxins are among the most potent biological molecules known:

  • Botulinum toxin (Clostridium botulinum) — blocks acetylcholine release at neuromuscular junctions; the most acutely lethal substance known (LD₅₀ ~1 ng/kg); 1 gram could theoretically kill 1 million people
  • Cholera toxin (Vibrio cholerae) — activates adenylyl cyclase in intestinal cells, causing massive chloride and water secretion; up to 20 liters of watery diarrhea per day
  • Shiga toxin (STEC E. coli) — inhibits protein synthesis in vascular endothelial cells; causes hemolytic uremic syndrome and kidney failure
  • Diphtheria toxin (Corynebacterium diphtheriae) — ADP-ribosylates elongation factor EF-2, halting all protein synthesis in target cells

Immune Evasion Strategies

Pathogens have evolved remarkable mechanisms to survive immune attack:

  • Capsule production — polysaccharide capsules resist phagocytosis; Streptococcus pneumoniae has 90+ distinct capsule types, each requiring specific antibodies
  • Intracellular survival — Mycobacterium tuberculosis survives inside macrophages by preventing phagosome-lysosome fusion
  • Antigenic variation — Borrelia recurrentis changes surface proteins to evade antibody recognition, causing relapsing fever
  • Superantigens — Staphylococcus aureus toxins activate massive numbers of T cells non-specifically, causing toxic shock

Biofilms: Bacterial Cities

Roughly 80% of chronic infections involve biofilms — structured communities of bacteria encased in a self-produced matrix of polysaccharides, proteins, and extracellular DNA. Biofilm bacteria are 100–1,000 times more resistant to antibiotics than planktonic (free-floating) bacteria. They form on medical implants (catheters, prosthetic joints), teeth (dental plaque), and in airways of cystic fibrosis patients.

Antibiotic Resistance

Resistance MechanismExampleHow It Works
Drug inactivationBeta-lactamase in MRSAEnzyme destroys penicillin ring
Target modificationVancomycin-resistant EnterococcusAltered peptidoglycan target
Efflux pumpsP. aeruginosaActively expels antibiotic from cell
Reduced permeabilityCarbapenem-resistant K. pneumoniaeLoss of porin channels blocks drug entry

The WHO estimates antimicrobial resistance could cause 10 million annual deaths by 2050 if unchecked — surpassing cancer as a leading cause of mortality. Understanding pathogenesis at the molecular level is essential for developing new antibiotics, vaccines, and anti-virulence strategies that target the weapons bacteria use without simply killing them (which would accelerate resistance evolution).

biologymicrobiologymedicine

Related Articles